Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologiesMAIA, Hugo; CASOY, Julio; PIMENTEL, Kleber et al.Contraception (Stoneham). 2008, Vol 78, Num 6, pp 479-485, issn 0010-7824, 7 p.Article

Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2GRANFORS, Marika T; BACKMAN, Janne T; LAITILA, Jouko et al.Clinical pharmacology and therapeutics. 2005, Vol 78, Num 4, pp 400-411, issn 0009-9236, 12 p.Article

Third generation oral contraceptive use and cardiovascular risk factorsDÖRING, Angela; FRÖHLICH, Margit; LÖWEL, Hannelore et al.Atherosclerosis. 2004, Vol 172, Num 2, pp 281-286, issn 0021-9150, 6 p.Article

Determination of steroid hormones in oral contraceptives by high-performance liquid chromatographySANTORO, Maria Inês R. M; KASSAB, Najla M; HASEGAWA, Maya et al.Drug development and industrial pharmacy. 2002, Vol 28, Num 6, pp 741-747, issn 0363-9045Article

Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteriesANGERER, Peter; STORK, Stefan; KOTHNY, Wolfgang et al.Maturitas (Amsterdam). 2002, Vol 41, Num 1, pp 51-60, issn 0378-5122Article

Latin American experience with two low-dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrelBASSOL, S; ALVARADO, A; PETRACCO, A et al.Contraception (Stoneham). 2000, Vol 62, Num 3, pp 131-135, issn 0010-7824Article

Nouvelles formes de contraception stéroïdienne = New forms of hormonal contraceptionGASPARD, U; BUICU, C; VAN DEN BRULE, F et al.Journal de gynécologie obstétrique et biologie de la reproduction. 2000, Vol 29, Num 3, pp 288-291, issn 0368-2315Conference Paper

Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolismANDERSEN, B. S; OLSEN, J; NIELSEN, G. L et al.Thrombosis and haemostasis. 1998, Vol 79, Num 1, pp 28-31, issn 0340-6245Article

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women : Results from the transnational study on oral contraceptives and the health of young womenLEWIS, M. A; HEINEMANN, L. A. J; SPITZER, W. O et al.Contraception (Stoneham). 1997, Vol 56, Num 3, pp 129-140, issn 0010-7824Article

Oral contraceptives and myocardial infarction : New evidence leaves unanswered questionsTHOROGOOD, M.Thrombosis and haemostasis. 1997, Vol 78, Num 1, pp 334-338, issn 0340-6245Conference Paper

Effect of 17α-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth musclesSEEGER, H; MÜCK, A. O; LORKOWSKI, G et al.Contraception (Stoneham). 1996, Vol 54, Num 4, pp 265-268, issn 0010-7824Article

Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young womenREBELO, Ana Cristina S; ZUTTIN, Roberta S; VERLENGIA, Rozangela et al.Contraception (Stoneham). 2010, Vol 81, Num 4, pp 309-315, issn 0010-7824, 7 p.Article

Evaluation of iron deficiency in young women in relation to oral contraceptive useCASABELLATA, Giorgia; DI SANTOLO, Manuela; BANFI, Giuseppe et al.Contraception (Stoneham). 2007, Vol 76, Num 3, pp 200-207, issn 0010-7824, 8 p.Article

Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 μg and ethinylestradiol 15 μg (Minesse®)BARBOSA, Ione C; FILHO, Carlos Isaia; FAGGION, Dirceu JR et al.Contraception (Stoneham). 2006, Vol 73, Num 1, pp 30-33, issn 0010-7824, 4 p.Article

Sexual behavior of women taking low-dose oral contraceptive containing 15 μg ethinylestradiol/60 μg gestodeneCARUSO, Salvatore; AGNELLO, Carmela; INTELISANO, Giorgia et al.Contraception (Stoneham). 2004, Vol 69, Num 3, pp 237-240, issn 0010-7824, 4 p.Article

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter studyContraception (Stoneham). 2003, Vol 67, Num 3, pp 173-185, issn 0010-7824, 13 p.Article

Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: A randomized placebo-controlled studyPOST, Marinka S; VAN DER MOOREN, Marius J; VAN BAAL, W. Marchien et al.American journal of obstetrics and gynecology. 2003, Vol 189, Num 5, pp 1221-1227, issn 0002-9378, 7 p.Article

Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal womenMERKI-FELD, Gabriele S; ROSSELLI, Marinella; DUBEY, Raghvendra K et al.Contraception (Stoneham). 2002, Vol 65, Num 3, pp 231-236, issn 0010-7824Article

Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene-environment interactionBLOEMENKAMP, Kitty W. M; DE MAAT, Moniek P. M; DERSJANT-ROORDA, Marianne C et al.Vascular pharmacology. 2002, Vol 39, Num 3, pp 131-136, issn 1537-1891, 6 p.Article

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrelENDRIKAT, J; CRONIN, M; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 3, pp 201-207, issn 0010-7824Article

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : A randomized, controlled trialANGERER, Peter; STORK, Stefan; KOTHNY, Wolfgang et al.Arteriosclerosis, thrombosis, and vascular biology. 2001, Vol 21, Num 2, pp 262-268, issn 1079-5642Article

The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolitesLEMUS, A. E; ZAGA, V; SANTILLAN, R et al.Journal of endocrinology. 2000, Vol 165, Num 3, pp 693-702, issn 0022-0795Article

Abdominal wall pain caused by cutaneous nerve entrapment in an adolescent girl taking oral contraceptive pillsPELEG, R.Journal of adolescent health. 1999, Vol 24, Num 1, pp 45-47, issn 1054-139XArticle

Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptivesVAN HEUSDEN, A. M; FAUSER, B. C. J. M.Contraception (Stoneham). 1999, Vol 59, Num 4, pp 237-243, issn 0010-7824Article

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activitySULLIVAN, H; FURNISS, H; SPONA, J et al.Fertility and sterility. 1999, Vol 72, Num 1, pp 115-120, issn 0015-0282Article